Delivery Order SPE2DB22D1202-SPE2DB24FUPJ9
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,306.91 and is a delivery order for the pharmaceutical product "XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML". The contract has an ultimate completion date of April 9, 2025 and a firm fixed price pricing type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This delivery order contract was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has a total ceiling value of $2,508.27 and an ultimate completion date of September 9, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts to supply a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,480.22 firm fixed-price delivery order is for the XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The award has a ceiling value of $1,106.92 and a completion date of March 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a ceiling value of $13,233.86 and a completion date of May 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.12 delivery order contract is for the supply of the medication XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.69, is a Firm Fixed Price Delivery Order for the medical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,300.21, is for the supply of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract has an ultimate completion date of March 5, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.09, is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to support military healthcare programs. This is a Firm Fixed Price Delivery Order contract with a completion date of November 12, 2024. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product, with a ceiling value of $2,533.36. The contract has a firm fixed price pricing type and is set to expire on January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...